SULT2B1 Inhibitors

Sulfotransferase 2B1 (SULT2B1) is an enzyme belonging to the sulfotransferase family, specifically involved in the phase II metabolism of endogenous and exogenous compounds. SULT2B1 plays a crucial role in the conjugation of hydroxysteroids, bile acids, and other lipophilic molecules with sulfonate groups, facilitating their excretion from the body. Inhibition of SULT2B1 has garnered significant attention in the field of chemical biology and drug discovery due to its potential implications in modulating the metabolic fate of various substrates.

SULT2B1 inhibitors are a class of chemical compounds specifically designed to impede the enzymatic activity of SULT2B1, thereby influencing the metabolic pathways of its substrates. These inhibitors are characterized by their ability to competitively or non-competitively bind to the active site of the enzyme, disrupting its catalytic function. Researchers have identified diverse chemical scaffolds with inhibitory potential against SULT2B1, ranging from small organic molecules to more complex structures. Understanding the structural determinants of SULT2B1 inhibition is crucial for the rational design and optimization of these inhibitors. The exploration of SULT2B1 inhibitors provides valuable insights into the intricate network of metabolic pathways and opens avenues for manipulating the sulfonation processes mediated by SULT2B1, which can have implications in diverse fields such as chemical biology.